Anzeige
Mehr »
Samstag, 12.07.2025 - Börsentäglich über 12.000 News
Der nächste Volltreffer direkt neben einer brandneuen Entdeckung! Kupfer im Höhenflug!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
1.108 Leser
Artikel bewerten:
(2)

INFORMA MARKETS - ENGINEERING: Axiom Space and Y-Combinator Female Powerhouse Speakers at BIOMEDevice Silicon Valley

SANTA CLARA, CA / ACCESSWIRE / October 24, 2023 / BIOMEDevice Silicon Valley, the leading West Coast medtech exhibition for engineers and cutting-edge medical device companies, announces Axiom Space, globally renowned space flight and infrastructure services, as well as Y-Combinator, the world's top-rated American technology startup accelerator, as its exclusive keynote speakers. Keynote topics will address significant challenges in healthcare through entrepreneurial stories and ingenious problem-solving focused on two respective case studies of early-stage detection of ovarian cancer, to the manufacturing of biomedical devices in space.

Surbhi Sarna, engineer, entrepreneur and partner at Y-Combinator and CEO, Founder of nVision, advocates and invests for innovation in healthcare. Sarna will discuss the origination of nVision and her personal journey from patient to pioneer, how nVision accomplished two FDA clearances and numerus clinical trials to develop the first-in-kind microcatheter for critical early-stage detection of ovarian cancer, a life-saving advancement in the research against the fifth most ranked disease in cancer related deaths among women.

Surbhi Sarna, engineer, entrepreneur and partner at Y-Combinator and CEO, Founder of nVision.

Pearly Pandya, In-Space Manufacturing and Biomedical Solutions at Axiom Space will detail the incredible insights and construction of the world's first commercial space station, Axiom, the successor to the International Space Station (ISS), where biomedical production and testing using microgravity as a platform will take place. Pandya will highlight findings such as retinal implants and fiber optics exclusively from Axiom Space Station which will be developed for use on earth and space. Axiom represents the next frontier for medical invention and the possibilities for advancement beyond the boundaries of Earth.

Pearly Pandya, In-Space Manufacturing and Biomedical Solutions at Axiom Space.

"The intersection of original discovery and creative technology use fuels modern healthcare transformation and these incredible presenting biomedical professionals have done just that -leading their respective industries to ground-breaking innovation," says Adrienne Zepeda, BIOMEDevice Event Director, Informa Markets Engineering. "Both of these women push the boundaries for biomedical progress, improving efficiency and accessibility of vital solutions for patients. BIOMEDevice serves as the catalyst to foster the pivotal knowledge and expertise like this to continue to drive remarkable discovery forward, as well as empowering the people and makers behind them."

Women make up only 34% of the workforce in science, technology, engineering and math (STEM). BIOMEDevice provides an educational outlet showcasing a diverse and talented workforce and a platform to inspire more young women to pursue careers in science.

Registration for BIOMEDevice Silicon Valley is available through?www.biomedevicesiliconvalley.com.

About Informa Markets Engineering: ??

Informa Markets Engineering portfolio, a subsidiary of Informa plc (LON:INF), is the leading B2B event producer, publisher, and digital media business for the world's $3-trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the engineering market and leverage our proprietary 1.3-million-name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Engineering portfolio is organized by Informa, the world's leading exhibitions organizer that brings a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit?www.informamarkets.com.??

Media Contact: ??

Jordan Douglas??
Informa Markets Engineering??
pr.ime@informa.com

SOURCE: ?INFORMA MARKETS - ENGINEERING

View source version on accesswire.com:
https://www.accesswire.com/795659/axiom-space-and-y-combinator-female-powerhouse-speakers-at-biomedevice-silicon-valley

© 2023 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.